Vyndaqel Articles
FDA now accepts Pfizer’s tafamidis NDA
16 February 2012
Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe
18 November 2011
Portuguese hospitals block access to new medicines as retail drug sector expected to meet savings goal
30 September 2011
Europe’s CHMP adopts positive opinions on Dexdor, Incivo, Plenadren, Vyndaqel and Zytiga; backs extensions
23 July 2011
Showing 1-8 of 8 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
